Development and evaluation of flubendazole inhalable nanoparticles for lung cancer treatmen (2023)
- Authors:
- Autor USP: MIYAGI, MARIANA YASUE SAITO - FCF
- Unidade: FCF
- Sigla do Departamento: FBF
- DOI: 10.11606/T.9.2023.tde-08032024-143847
- Subjects: NEOPLASIAS PULMONARES; DELINEAMENTO EXPERIMENTAL; NANOPARTÍCULAS
- Keywords: Câncer de pulmão; Delineamento experimental; Design of experiments; Inalatório; Lung cancer; Nanoparticles; nanopartículas; Pulmonary delivery; Spray drying; Spray drying
- Agências de fomento:
- Language: Inglês
- Abstract: Lung cancer is the leading cause of cancer-related death. In addition to new innovative approaches, practical strategies that improve the efficacy of already available drugs are urgently needed. Inhalable administration of chemotherapy is a promising alternative to increase efficacy, reduce toxicity, and improve patients quality of life in a more embracing way than immunotherapy. Since it is a new approach in an incipient field of research, there are many challenges to be overcome before having such a product on the market. After evaluating the current scenario, an inhalable dry powder formulation was proposed to reposition flubendazole, a poorly soluble anthelmintic drug with potential against a variety of cancer lineages. Flubendazole nanocrystals were obtained through nanoprecipitation, and dry powder was produced by spray drying. Through fractional factorial design, the spray drying parameters were optimized and the impact of formulation on aerosolization properties was clarified. The loading limitations were clarified through response surface methodology, and a 15% flubendazole loading was feasible through the addition of 20% L-leucine, leading to a flubendazole particle size of 388.6 nm, median mass aerodynamic diameter of 2.9 µm, 50.3% FPF, emitted dose of 83.2% and triple the initial solubility. Although the cytotoxicity of this formulation in A549 cells was limited, the formulation showed a synergistic effect when associated with paclitaxel, leading to a surprising 1000-fold reduction in the IC50. Compared to 3 cycles of paclitaxel alone, a 3-cycle model combined treatment increased the threshold of cytotoxicity by 25% for the same dose. Our study suggests, for the first time, that orally inhaled flubendazole nanocrystals show high potential as adjuvants to increase cytotoxic agents potency and reduce adverse effects
- Imprenta:
- Data da defesa: 27.11.2023
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
MIYAGI, Mariana Yasue Saito. Development and evaluation of flubendazole inhalable nanoparticles for lung cancer treatmen. 2023. Tese (Doutorado) – Universidade de São Paulo, São Paulo, 2023. Disponível em: https://www.teses.usp.br/teses/disponiveis/9/9139/tde-08032024-143847/. Acesso em: 27 jan. 2026. -
APA
Miyagi, M. Y. S. (2023). Development and evaluation of flubendazole inhalable nanoparticles for lung cancer treatmen (Tese (Doutorado). Universidade de São Paulo, São Paulo. Recuperado de https://www.teses.usp.br/teses/disponiveis/9/9139/tde-08032024-143847/ -
NLM
Miyagi MYS. Development and evaluation of flubendazole inhalable nanoparticles for lung cancer treatmen [Internet]. 2023 ;[citado 2026 jan. 27 ] Available from: https://www.teses.usp.br/teses/disponiveis/9/9139/tde-08032024-143847/ -
Vancouver
Miyagi MYS. Development and evaluation of flubendazole inhalable nanoparticles for lung cancer treatmen [Internet]. 2023 ;[citado 2026 jan. 27 ] Available from: https://www.teses.usp.br/teses/disponiveis/9/9139/tde-08032024-143847/ - Optimizing adjuvant inhaled chemotherapy: synergistic enhancement in paclitaxel cytotoxicity by flubendazole nanocrystals in a cycle model approach
- Revisiting flubendazole through nanocrystal technology: statistical design, characterization and its potential inhibitory effect on xenografted lung tumor progression in mice
- Unveiling microtubule dynamics in lung cancer: recent findings and prospects for drug delivery and treatment
- Rational design of oral flubendazole-loaded nanoemulsion for brain delivery in Cryptococcosis
- Malignant wound – The influence of oil components in flubendazole-loaded nanoemulsions in A549 lung cancer xenograft-bearing mice
- The lack of PI3Kγ favors M1 macrophage polarization and does not prevent kidney diseases progression
Informações sobre o DOI: 10.11606/T.9.2023.tde-08032024-143847 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
